Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Pancreas (Late Stage^), 2016-2020

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by CI*Rank
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 9.7 (9.7, 9.8) N/A 38,462 73.9
New York 3 11.2 (11.0, 11.4) 1 (1, 7) 2,797 77.6
Connecticut 3 11.1 (10.7, 11.6) 2 (1, 11) 534 79.9
Pennsylvania 6 11.1 (10.9, 11.3) 3 (1, 8) 1,977 76.5
New Jersey 3 11.1 (10.8, 11.3) 4 (1, 9) 1,259 74.7
Louisiana 3 11.0 (10.7, 11.5) 5 (1, 11) 622 78.4
Georgia 3 10.7 (10.4, 10.9) 6 (3, 16) 1,258 80.6
Iowa 3 10.6 (10.1, 11.0) 7 (1, 24) 433 78.0
Wisconsin 6 10.5 (10.2, 10.9) 8 (4, 21) 807 75.4
Illinois 3 10.5 (10.2, 10.7) 9 (5, 19) 1,640 74.8
Rhode Island 6 10.4 (9.7, 11.2) 10 (1, 33) 146 76.5
South Dakota 6 10.4 (9.5, 11.3) 11 (1, 36) 115 77.6
Massachusetts 3 10.4 (10.1, 10.7) 12 (5, 23) 920 74.4
Mississippi 6 10.3 (9.9, 10.8) 13 (4, 28) 383 75.8
Idaho 3 10.3 (9.7, 11.0) 14 (1, 32) 216 75.8
District of Columbia 6 10.2 (9.1, 11.3) 15 (1, 43) 70 68.1
Michigan 6 10.2 (9.9, 10.4) 16 (8, 26) 1,345 74.2
Delaware 6 10.1 (9.4, 11.0) 17 (1, 38) 139 73.8
Washington 5 10.1 (9.8, 10.4) 18 (8, 28) 915 77.3
North Carolina 6 10.1 (9.9, 10.4) 19 (9, 27) 1,327 77.1
Hawaii 3 10.1 (9.5, 10.8) 20 (2, 36) 193 74.1
Kentucky 3 10.1 (9.7, 10.5) 21 (7, 29) 577 76.0
Ohio 6 10.0 (9.8, 10.2) 22 (12, 29) 1,532 72.7
West Virginia 6 9.9 (9.3, 10.5) 23 (6, 37) 259 75.9
Maryland 6 9.9 (9.6, 10.2) 24 (11, 32) 734 72.8
South Carolina 6 9.8 (9.5, 10.2) 25 (12, 34) 669 73.6
New Hampshire 6 9.8 (9.2, 10.5) 26 (6, 39) 185 72.6
Missouri 6 9.6 (9.3, 9.9) 27 (18, 36) 764 73.4
Nebraska 6 9.6 (9.0, 10.2) 28 (11, 42) 222 73.0
Maine 6 9.5 (8.9, 10.1) 29 (12, 43) 197 70.1
Minnesota 6 9.4 (9.1, 9.8) 30 (21, 39) 657 67.4
Florida 6 9.4 (9.3, 9.6) 31 (25, 36) 2,990 72.6
Alaska 6 9.4 (8.3, 10.5) 32 (5, 48) 69 72.6
Oregon 6 9.3 (9.0, 9.7) 33 (23, 41) 515 73.3
Montana 6 9.2 (8.5, 10.0) 34 (13, 47) 134 74.8
Vermont 6 9.2 (8.3, 10.1) 35 (9, 48) 83 71.9
California 3 9.1 (9.0, 9.3) 36 (31, 40) 4,077 75.5
Arkansas 6 9.1 (8.7, 9.6) 37 (23, 44) 353 73.3
Kansas 6 9.0 (8.5, 9.4) 38 (27, 46) 321 76.5
North Dakota 6 8.8 (8.0, 9.8) 39 (14, 48) 80 76.1
Texas 3 8.8 (8.7, 9.0) 40 (35, 44) 2,583 69.2
Virginia 6 8.8 (8.5, 9.1) 41 (33, 46) 921 70.7
Tennessee 6 8.8 (8.5, 9.0) 42 (34, 46) 752 69.6
Utah 3 8.5 (8.0, 9.0) 43 (32, 48) 239 75.4
Colorado 6 8.5 (8.2, 8.8) 44 (37, 48) 544 73.6
Oklahoma 6 8.4 (8.0, 8.8) 45 (37, 48) 406 70.2
Wyoming 6 8.4 (7.4, 9.4) 46 (23, 49) 62 74.7
Alabama 6 8.3 (8.0, 8.6) 47 (40, 48) 530 64.3
Arizona 6 8.2 (7.9, 8.4) 48 (42, 48) 767 68.4
New Mexico 3 7.2 (6.7, 7.7) 49 (48, 49) 198 62.6
Indiana 6
data not available
N/A
data not available
data not available
Nevada 6
data not available
N/A
data not available
data not available
Puerto Rico 6 5.3 (5.0, 5.6) N/A 230 63.1
Notes:
Created by statecancerprofiles.cancer.gov on 07/19/2024 4:32 am.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana, Nevada, Puerto Rico

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top